European Neurology
Original Paper
Prestroke Dementia: Characteristics and Clinical Features in Consecutive Series of PatientsCaratozzolo S. · Riva M. · Vicini Chilovi B. · Cerea E. · Mombelli G. · Padovani A. · Rozzini L.Department of Neurology, University of Brescia, Brescia, Italy
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: January 24, 2013
Accepted: August 18, 2013
Published online: January 03, 2014
Issue release date: April 2014
Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 4
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Abstract
Background/Aim: The prestroke level of cognitive function should be taken into account in order to predict the impact of stroke on the subsequent risk of dementia. The aim of the present study was to investigate the presence and correlates of prestroke dementia (PSD) as well as to identify its clinical features. Methods: Premorbid clinical and cognitive features of 158 consecutively recruited patients with a diagnosis of acute cerebrovascular pathology were assessed by interviewing the caregivers using multidimensional assessment. Patients were divided into two groups (PSD group and prestroke nondemented group). Baseline cognitive, functional and behavioral variables and neuroradiological hallmarks (medial temporal lobe atrophy, MTLA) were compared between these two groups. Results: In a logistic regression model, older age (OR 1.05), female gender (OR 2.3), Neuropsychiatric Inventory total score (OR 1.1) and MTLA (OR 1.2) were the variables independently associated with PSD. Conclusions: These findings support the hypothesis that cognitive impairment in patients with stroke may not only be a direct consequence of the acute cerebrovascular event but also a consequence of underlying neurodegenerative pathology.
© 2014 S. Karger AG, Basel
Related Articles:
References
- Murray CJ, Lopez AD: Alternative projection of mortality and disability by cause 1990-2020: global burden of disease. Lancet 1997;349:1498-1504.
- Tatemichi TK, Paik M, Bagiella E, et al: Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 1994;44:1885-1891.
-
Hénon H, Durieu I, Lucas C, et al: Prevalence of pre-existing dementia in consecutive stroke patients. Neurology 1996;47:852-853.
- Pasquier F, Leys D: Why are stroke patients prone to develop dementia? J Neurol 1997;244:135-142.
- Frisoni GB, Bianchetti A, Geroldi C, et al: Measures of medial temporal lobe atrophy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1994;57:1438-1439.
- O'Sullivan M: Prestroke cognitive function and cerebrovascular disease: if they interact, it may not be through symptomatic stroke. Stroke 2008;39:3-4.
- Nys GMS, van Zandvoort MJE, de Kort PLM, Jansen BPW, Kappelle LJ, de Haana EHF: Restrictions of the Mini-Mental State Examination in acute stroke. Arch Clin Neuropsychol 2005;20:623-629.
- Mahoney FI, Barthel D: Functional evaluation: the Barthel Index. Md State Med J 1965;14:56-61.
- Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
- Granger CV, Sherwood CC, Greer DS: Functional status measures in a comprehensive stroke care program. Arch Phys Med Rehabil 1977;58:555-561.
- Jorm AF: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): a review. Int Psychogeriatr 2004;16:275-293.
- Mackinnon A, Mulligan R: Combining cognitive testing and informant report to increase accuracy in screening for dementia. Am J Psychiatry 1998;155:1529-1535.
- Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D: Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology 2001;57:1216-1222.
- Klimkowicz A, Dziedzic T, Slowik A, Szczudlik A: Incidence of pre- and poststroke dementia: Cracow Stroke Registry. Dement Geriatr Cogn Disord 2002;14:137-140.
- Cummings JL, Masterman DL: Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease. J Clin Psychiatry 1998;59:23-30.
- Lyketsos C, Steinberg M, Tschanz JT, et al: Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000;157:708-714.
- Cummings JL, Mega M, Gray K, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
- Jobst KA, Smith AD, Szatmari M, et al: Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet 1992;340:1179-1183.
- Pasquier F, Hamon M, Lebert F, et al: Medial temporal lobe atrophy in memory disorders. J Neurol 1997;244:175-181.
- Adams HPJ, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
- Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991;337:1521-1526.
- Hatano S: Experience from a multicenter stroke register: a preliminary report. Bull World Health Organ 1976;54:541-553.
- Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH Stroke Scale. Arch Neurol 1989;46:660-662.
- Van Swieten JC, Hijdra A, Koudstaal PJ, van Gijn J: Grading white matter lesions on CT and MRI: a simple scale. J Neurosurg Psychiatry 1990;53:1080-1083.
- Jorm AF: A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) - development and crossvalidation. Psychol Med 1994;24:145-153.
-
SPSS Inc: SPSS Base 18.0.3 for MAC User's Guide. SPSS, Chicago, 2010.
- Pendlebury ST, Rothwell PM: Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009;8:1006-1018.
- Barba R, Castro MD, Morin M, Rodriguez-Romero R, Rodriguez Garcia E, Canton R, Del Serb T: Prestroke dementia. Cerebrovasc Dis 2001;11:216-224.
- Zhu L, Fratiglioni L, Guo Z, Winblad B, Viitanen M: Incidence of stroke in relation to cognitive function and dementia in the Kungsholmen Project. Neurology 2000;54:2103-2107.
- Garibotto V, Borroni B, Sorbi S, Cappa SF, Padovani A, Perani D: Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease. Neurol Sci 2012;33:1037-1042.
-
McCullagh CD, Craig D, McIlroy PS, Passmore AP: Risk factors for dementia. Adv Psychiatr Treat 2001;7:24-31.
External Resources
- Herbert LE, Scherr PS, McCann JJ, Beckett LA, Evans DA: Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol 2001;153:132-136.
- Simpkins JW, Perez PE, Wang X, Yang S, Wen Y, Singh M: The potential for estrogens in preventing Alzheimer's disease and vascular dementia. Ther Adv Neurol Disord 2009;21:31-49.
- Pohjasvaara T, Mantyla R, Aronen HJ, Leskela M, Salonem O, Kaste M: Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort. J Neurol Neurosurg Psychiatry 1999;67:742-748.
- Rozzini L, Vicini Chilovi B, Conti M, Delrio I, Borroni B, Trabucchi M, Padovani A: Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord 2008;25:32-36.
- Vicini Chilovi B, Conti M, Zanetti M, Mazzu I, Rozzini L, Padovani A: Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients. Dement Geriatr Cogn Disord 2009;27:390-398.
- Rozzini L, Chilovi BV, Peli M, Conti M, Rozzini R, Trabucchi M, Padovani A: Anxiety symptoms in mild cognitive impairment. Int J Geriatr Psychiatry 2009;24:300-305.
-
Jobst KA, Lin PD, Shepstone BJ: Accurate prediction of histologically confirmed Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996;46:678-681.
- Willmer J, Carruthers A, Guzman DA, Collins B, Pogue J, Stuss DT: The usefulness of CT scanning in diagnosing dementia of the Alzheimer type. Can J Neurol Sci 1993;20:210-216.
- Padovani A, Gilberti N, Borroni B: The usefulness of biological and neuroimaging markers for the diagnosis of early-onset Alzheimer's disease. Int J Alzheimers Dis 2011;21:296-374.
Article / Publication Details
Received: January 24, 2013
Accepted: August 18, 2013
Published online: January 03, 2014
Issue release date: April 2014
Number of Print Pages: 7
Number of Figures: 0
Number of Tables: 4
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission